Founding teams can conduct research at MAxL free of charge for one year
The Japanese pharmaceutical company Daiichi Sankyo has become a “Golden Ticket” sponsor of the BioM incubator MAxL (Munich Accelerator Life Sciences & Medicine). Through this partnership, Daiichi Sankyo specifically supports emerging biotech start-ups thereby making an important contribution to promoting innovative therapeutic approaches in the biomedical field.
The incubator, managed by BioM, is specifically designed to support pre-seed and early-stage start-up teams in the life sciences and healthtech sectors. It is intended to facilitate the translation of scientific findings into market-ready products thereby filling an important gap in the start-up ecosystem.
MAxL's Golden Ticket program enables an outstanding founding team to advance its research work in the incubator's state-of-the-art laboratory and co-working space free of charge for one year. The team also benefits from... [read more]